Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 247 clinical trials
Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

The TRACK trial is an investigator-initiated, multicentre, prospective, randomised, double-blind, placebo-controlled trial. TRACK is a global trial and will be conducted in renal units that provide comprehensive CKD care. Approximately 2000 participants will be recruited. The TRACK trial will assess a strategy of administering low dose rivaroxaban to reduce the …

dialysis
  • 2 views
  • 22 Dec, 2021
  • 34 locations
Danish Cardiovascular Screening Trial II (DANCAVAS-II)

This study attempts to reduce social inequality in cardiovascular health by performing an interventional screening trial on how best to decrease cardiovascular disease (CVD) among people with low social status.

cardiovascular disease
  • 13 views
  • 06 Feb, 2022
  • 4 locations
Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome (ANDAMAN)

To compare treatment with Aspirin Protect twice a day (100 mg in the morning and 100 mg in the evening) versus Aspirin Protect 100 mg once per day on a composite end-point of ischemic events in diabetic patients, or in patients with a known risk factor for non-optimal aspirin response …

angiography
troponin
fasting
q waves
obesity
  • 0 views
  • 25 Jan, 2022
  • 1 location
Integrated Patient Care Intradialysis Programme in Hemodialysis Through a Virtual Health Platform

There is wide evidence regarding the weak points of end-stage Chronic kidney disease (CKD) patients in hemodialysis, and they include three intervention aspects: exercise, nutrition and psychological support. Evidence shows that exercise for patients in hemodialysis results in increased survival rate, functional capacity, strength and health-related quality of life. Additionally, …

dialysis
  • 0 views
  • 08 Aug, 2021
  • 7 locations
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in MI Patients

Background: Potent antithrombotic therapy has improved prognosis for patients with acute myocardial infarction (MI) significantly, however, at a price of increased bleeding risk. Helicobacter pylori (H. pylori) infection commonly causes upper gastrointestinal bleeding (UGIB). If systematic screening for H. pylori and subsequent eradication therapy significantly reduces the risk of UGIB …

heart failure
infarct
stroke
myocardial infarction
fasting
  • 0 views
  • 01 Dec, 2021
  • 35 locations
Transfusion Trigger After Operations in High Cardiac Risk Patients (TOP)

The goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb < 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative outcomes compared to a restrictive transfusion …

percutaneous coronary intervention
Accepts healthy volunteers
angina pectoris
exercise stress test
bypass surgery
  • 12 views
  • 12 Apr, 2022
  • 14 locations
SHOWME-PAD (Peripheral Artery Disease)

The overall goal of SHOWME-PAD is to make the existing evidence-base on treatment outcomes -focusing on health status outcomes that reflect the patients' perspective - more transparently available to patients and providers, such that more informed, evidence-based shared treatment decisions occur. INTEGRITY-PAD has the potential to radically reorganize care delivery …

peripheral arterial diseases
angiography
arteriopathy
  • 9 views
  • 21 Apr, 2022
  • 1 location
Liraglutide and Peripheral Artery Disease

-metabolic risk factors, in people with type 2 diabetes and peripheral artery disease. The potential benefits for participants in the study include the possibility of improving peripheral perfusion with

atherosclerosis
diabetes
sulfonylurea
metformin
hypertension
  • 0 views
  • 21 Jun, 2021
  • 1 location
Improving Walking in Peripheral Artery Disease

Peripheral artery disease (PAD) is a cardiovascular disease manifesting from systemic atherosclerosis that blocks the leg arteries and results in insufficient blood flow to the lower extremities

  • 0 views
  • 11 Nov, 2021
  • 1 location
Red Light Treatment in Peripheral Artery Disease

Subjects with a known diagnosis of peripheral artery disease as measured by an abnormal ankle brachial index (<.9 or >1.1) will undergo a single 5 min exposure of 670 nm light, 1 cm above

  • 0 views
  • 30 May, 2022
  • 1 location